A 24-month retrospective update: follow-up hospitalization charges and readmissions in US lumbar fusion surgeries using a cellular bone allograft (CBA) versus recombinant human bone morphogenetic protein-2 (rhBMP-2)

Wetzell, Bradley; McLean, Julie B.; Dorsch, Kimberly; Moore, Mark A.

doi:10.1186/s13018-021-02829-0

Article metrics
Last updated: Thu, 25 Apr 2024 11:53:00 Z

A 24-month retrospective update: follow-up hospitalization charges and readmissions in US lumbar fusion surgeries using a cellular bone allograft (CBA) versus recombinant human bone morphogenetic protein-2 (rhBMP-2)

Access & Citations

903

Article Accesses
2

Web of Science
3

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.